Lexpos News

Contractors are currently voting in four PSNC regional representative ballots and PSNC’s (national) non-CCA Multiple representatives ballot. The voting allocations for the ballots are based on PSNC records of contractors’ NHS pharmacy premises in the PSNC region or England, as relevant, and earlier this year PSNC invited contractors to check these records and request changes. [...]

The post PSNC Elections – last stage of voting appeared first on PSNC Website.

Pharmacy leaders are set to brief MPs on the severe challenges facing community pharmacies this week as part of a wave of #SaveOurPharmacies campaign activities. Tomorrow’s (Tuesday 21st March) roundtable summit will include discussions on the urgent action needed to address the current severe challenges being faced by community pharmacy, as well as the sector’s [...]

The post Save our Pharmacies campaign gains momentum appeared first on PSNC Website.

Update 05/05/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Paracetamol 240mg suppository (SSP051) was due to expire 5 May 2023 but have been further extended to Friday 12 May 2023. In response to a significant ongoing disruption to the supply of Paracetamol [...]

The post Extension to Paracetamol 240mg suppositories (SSP051) appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 100mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP049 Estradot® 100mcg patches expires at 23.59pm on Friday 17 March 2023. After this date, any prescriptions for Estradot® 100mcg patches must be [...]

The post Contractor Notice: Expiry of SSP049 Estradot® 100mcg patches appeared first on PSNC Website.

Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (23)A/10 Date issued: 16 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 150mg prolonged-release tablets, PL01883/0340 SNOMED Code: 41468211000001100 Batch [...]

The post MHRA Class 4 Medicines Defect Information: Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) appeared first on PSNC Website.